IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity. NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.

AIDS Res Hum Retroviruses. 1997 Oct 10;13(15):1263-72. Unique Identifier : AIDSLINE MED/97479762
Black KP; Fultz PN; Girard M; Jackson S; Department of Microbiology, University of Alabama at Birmingham,; 35294-2170, USA.


Abstract: HIV infection in humans causes various aberrancies in both the cellular and humoral immune systems, including functional abnormalities of B lymphocytes. In many instances, dysfunction occurs in the regulation of serum IgA, resulting in elevated concentrations of this immunoglobulin isotype. To determine whether HIV-1-infected chimpanzees develop IgA abnormalities similar to those observed in humans, we quantified total IgA, IgG, and IgM levels in sera collected longitudinally from six HIV-infected chimpanzees and one uninfected control animal. In comparison to immunoglobulin levels in the uninfected animal, two of the six infected chimpanzees exhibited increases in serum immunoglobulins following infection with HIV. Two other infected animals showed a marked decrease in the three isotypes within 10 months of exposure to HIV, followed by a return to baseline levels. The remaining two HIV-infected chimpanzees displayed serum immunoglobulin levels that paralleled the baseline levels and did not show great deviation over a period of 20 to 45 months postinfection. ELISA analyses of the IgA subclasses revealed possible abnormalities of the IgA2 subclass within the two animals that did not display irregular IgA, IgG, or IgM responses to HIV-1. Specific IgG, IgA, IgA1, and IgA2 antibodies to HIV antigens were detected by an enzyme immunoassay (EIA) kit and by Western blot analysis with IgA, IgA1, and IgA2 antibodies directed against the env, gag, and pol gene products. Because IgG can mask the detection of HIV-specific IgA antibodies in infected humans, Western blots and EIAs were also performed on IgG-depleted chimpanzee sera. The results demonstrated that in some instances, IgA reactivity against HIV antigens can be enhanced on removal of IgG. This study indicates that HIV-1 is capable of inducing abnormalities in serum IgA expression in chimpanzees. These results might further understanding of how HIV affects humoral responses in infected humans.
Keywords: Animal Blotting, Western Enzyme-Linked Immunosorbent Assay Gene Products, env/IMMUNOLOGY Gene Products, pol/IMMUNOLOGY HIV Antibodies/*ANALYSIS/BLOOD/IMMUNOLOGY HIV Antigens/IMMUNOLOGY HIV Core Protein p24/IMMUNOLOGY HIV Infections/BLOOD/*IMMUNOLOGY HIV-1/*IMMUNOLOGY IgA/ANALYSIS/BLOOD/*IMMUNOLOGY IgG/ANALYSIS/BLOOD/IMMUNOLOGY IgM/ANALYSIS/BLOOD/IMMUNOLOGY Longitudinal Studies Male Pan troglodytes Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLEKWDanimalblotting,westernenzyme-linkedimmunosorbentassaygeneproducts,env/immunologygeneproducts,pol/immunologyhivantibodies/KWDanalysis/blood/immunologyhivantigens/immunologyhivcoreproteinp24/immunologyhivinfections/blood/KWDimmunologyhiv-1/KWDimmunologyiga/analysis/blood/KWDimmunologyigg/analysis/blood/immunologyigm/analysis/blood/immunologylongitudinalstudiesmalepantroglodytessupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDjournalarticle
980228
M9820727

Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .